Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Pain × Fentanyl × Clear all

Phase

Phase 4 7 Phase 3 7 Phase 2 3 Phase NA 2 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1

Interventions

Lidocaine 3 aluminum hydroxide, magnesium hydroxide, drug combination 1 Water 1 Transdermal Patch 1 Radiosurgery 1 Methadone 1 Melatonin 1 Glucose 1 Fentanyl 1 Diphenhydramine 1 Diazepam 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00644787 2013-06-13

A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain

Janssen Pharmaceutical K.K.

Phase 2/3 Completed

156 enrolled 14 charts

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡